Suppr超能文献

中文期刊发表的中医药干预系统评价的流行病学、质量和报告特征。

Epidemiology, quality and reporting characteristics of systematic reviews of traditional Chinese medicine interventions published in Chinese journals.

机构信息

Evidence-Based Medicine Center, Institute of Traditional Chinese and Western Medicine, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China.

出版信息

PLoS One. 2011;6(5):e20185. doi: 10.1371/journal.pone.0020185. Epub 2011 May 25.

Abstract

BACKGROUND

Systematic reviews (SRs) of TCM have become increasingly popular in China and have been published in large numbers. This review provides the first examination of epidemiological characteristics of these SRs as well as compliance with the PRISMA and AMSTAR guidelines.

OBJECTIVES

To examine epidemiological and reporting characteristics as well as methodological quality of SRs of TCM published in Chinese journals.

METHODS

Four Chinese databases were searched (CBM, CSJD, CJFD and Wanfang Database) for SRs of TCM, from inception through Dec 2009. Data were extracted into Excel spreadsheets. The PRISMA and AMSTAR checklists were used to assess reporting characteristics and methodological quality, respectively.

RESULTS

A total of 369 SRs were identified, most (97.6%) of which used the terms systematic review or meta-analysis in the title. None of the reviews had been updated. Half (49.8%) were written by clinicians and nearly half (47.7%) were reported in specialty journals. The impact factors of 45.8% of the journals published in were zero. The most commonly treated conditions were diseases of the circulatory and digestive disease. Funding sources were not reported for any reviews. Most (68.8%) reported information about quality assessment, while less than half (43.6%) reported assessing for publication bias. Statistical mistakes appeared in one-third (29.3%) of reviews and most (91.9%) did not report on conflict of interest.

CONCLUSIONS

While many SRs of TCM interventions have been published in Chinese journals, the quality of these reviews is troubling. As a potential key source of information for clinicians and researchers, not only were many of these reviews incomplete, some contained mistakes or were misleading. Focusing on improving the quality of SRs of TCM, rather than continuing to publish them in great quantity, is urgently needed in order to increase the value of these studies.

摘要

背景

系统评价(SR)在中国的中医药领域越来越受欢迎,并已大量发表。本研究首次对这些 SR 的流行病学特征以及对 PRISMA 和 AMSTAR 指南的遵循情况进行了检查。

目的

检查在中国期刊上发表的中医药系统评价的流行病学和报告特征以及方法学质量。

方法

从建库到 2009 年 12 月,在中国生物医学文献数据库(CBM)、中国学术期刊全文数据库(CSJD)、中国期刊全文数据库(CJFD)和万方数据库中搜索中医药系统评价。将数据提取到 Excel 电子表格中。使用 PRISMA 和 AMSTAR 清单分别评估报告特征和方法学质量。

结果

共确定了 369 篇 SR,其中 97.6%的标题中使用了“系统评价”或“meta 分析”一词。没有一篇综述得到更新。其中一半(49.8%)由临床医生撰写,近一半(47.7%)发表在专业期刊上。发表这些综述的期刊的影响因子有 45.8%为零。最常见的治疗疾病是循环系统疾病和消化系统疾病。没有一篇综述报告了资金来源。大多数(68.8%)报告了质量评估信息,而不到一半(43.6%)报告了发表偏倚的评估。三分之一(29.3%)的综述存在统计错误,大多数(91.9%)没有报告利益冲突。

结论

虽然中国期刊上发表了许多中医药干预措施的系统评价,但这些评价的质量令人担忧。由于这些系统评价可能是临床医生和研究人员的重要信息来源,因此不仅许多评价不完整,有些还存在错误或具有误导性。为了提高这些研究的价值,迫切需要关注提高中医药系统评价的质量,而不是继续大量发表。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a9b/3102106/3307904d03f8/pone.0020185.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验